Pharmacogenomics in lung cancer treatment
dc.contributor.author | Duman, Demet Cansaran | |
dc.contributor.authorID | http://orcid.org/0000-0001-5662-2333 | tr_TR |
dc.contributor.department | Biyoteknoloji Enstitüsü | tr_TR |
dc.contributor.other | Kılıç, Nil | |
dc.date.accessioned | 2020-05-08T07:42:36Z | |
dc.date.available | 2020-05-08T07:42:36Z | |
dc.date.issued | 2017 | |
dc.description.abstract | Lung carcinoma is the most common cause of cancer-related death in men among other cancer types in last years. The most recent and significant step in the treatment of the disease is the determination of the human genome structure and understanding of tumor biology. Pharmacogenomics examines tumordependent gene mutations to determine in which patient the drug will be more effective. Personalized treatments that are specified directly to disease by using pharmacogenomics methods are applied to cure patients with minimum side effects. Also, determining sensitivity of drug against tumor by examining gene mutations in patients plays a crucial role in selection and outcome of treatment. Patient-specific pharmacogenetic applications in lung carcinoma treatment and their effects on prognostic of disease were reviewed in this study. | tr_TR |
dc.identifier.endpage | 184 | tr_TR |
dc.identifier.issue | 2 | tr_TR |
dc.identifier.startpage | 175 | tr_TR |
dc.identifier.uri | https://doi.org/10.5505/TurkHijyen.2017.21703 | tr_TR |
dc.identifier.uri | http://hdl.handle.net/20.500.12575/71223 | |
dc.identifier.volume | 74 | tr_TR |
dc.language.iso | en | tr_TR |
dc.relation.isversionof | 10.5505/TurkHijyen.2017.21703 | tr_TR |
dc.relation.journal | Turk Hijyen ve Deneysel Biyoloji Dergisi | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | tr_TR |
dc.subject | Lung cancer | tr_TR |
dc.subject | Pharmacogenomic | tr_TR |
dc.title | Pharmacogenomics in lung cancer treatment | tr_TR |
dc.title.alternative | Akciğer kanseri tedavisinde farmakogenomik | tr_TR |
dc.type | Article | tr_TR |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- CC_DD_Pharmacogenomics in lung cancer treatment_.pdf
- Size:
- 980.5 KB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.62 KB
- Format:
- Item-specific license agreed upon to submission
- Description: